120 related articles for article (PubMed ID: 27608899)
41. Neoadjuvant chemotherapy in ER+ HER2- breast cancer: response prediction based on immunohistochemical and molecular characteristics.
Lips EH; Mulder L; de Ronde JJ; Mandjes IA; Vincent A; Vrancken Peeters MT; Nederlof PM; Wesseling J; Rodenhuis S
Breast Cancer Res Treat; 2012 Feb; 131(3):827-36. PubMed ID: 21472434
[TBL] [Abstract][Full Text] [Related]
42. Expression of epithelial-mesenchymal transition driver brachyury and status of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in predicting treatment responses to neoadjuvant chemotherapy of breast cancer.
Lee KH; Kim EY; Park YL; Do SI; Chae SW; Park CH
Tumour Biol; 2017 Jun; 39(6):1010428317710575. PubMed ID: 28621227
[TBL] [Abstract][Full Text] [Related]
43. Role of p-glycoprotein expression in predicting response to neoadjuvant chemotherapy in breast cancer--a prospective clinical study.
Chintamani ; Singh JP; Mittal MK; Saxena S; Bansal A; Bhatia A; Kulshreshtha P
World J Surg Oncol; 2005 Sep; 3():61. PubMed ID: 16164742
[TBL] [Abstract][Full Text] [Related]
44. Crystal Structure and Substrate Specificity of PTPN12.
Li H; Yang F; Liu C; Xiao P; Xu Y; Liang Z; Liu C; Wang H; Wang W; Zheng W; Zhang W; Ma X; He D; Song X; Cui F; Xu Z; Yi F; Sun JP; Yu X
Cell Rep; 2016 May; 15(6):1345-58. PubMed ID: 27134172
[TBL] [Abstract][Full Text] [Related]
45. [Correlation of expression of Survivin, BCRP and HER-2 genes with therapeutic response of TE regimen neoadjuvant chemotherapy in breast cancer patients].
Li X; Li Y; Yang SE; Ma Y; Wen SJ; Guo L; Guli KZ; Zhao B; Liu W; Hu X
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):916-20. PubMed ID: 22340101
[TBL] [Abstract][Full Text] [Related]
46. Tumor topoisomerase II alpha status and response to anthracycline-based neoadjuvant chemotherapy in breast cancer.
Nikolényi A; Sükösd F; Kaizer L; Csörgo E; Vörös A; Uhercsák G; Ormándi K; Lázár G; Thurzó L; Brodowicz T; Kahán Z
Oncology; 2011; 80(3-4):269-77. PubMed ID: 21734419
[TBL] [Abstract][Full Text] [Related]
47. Assessment of predictive markers of response to neoadjuvant chemotherapy in breast cancer.
Tewari M; Pradhan S; Singh U; Singh TB; Shukla HS
Asian J Surg; 2010 Oct; 33(4):157-67. PubMed ID: 21377101
[TBL] [Abstract][Full Text] [Related]
48. Progress in the correlation between PTPN12 gene expression and human tumors.
Huo YH; Wang YN; Meng LB; Zhang AL; Liu B
Medicine (Baltimore); 2020 Jun; 99(24):e20445. PubMed ID: 32541467
[TBL] [Abstract][Full Text] [Related]
49. FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer.
Kawase M; Toyama T; Takahashi S; Sato S; Yoshimoto N; Endo Y; Asano T; Kobayashi S; Fujii Y; Yamashita H
Breast Cancer; 2015 May; 22(3):308-16. PubMed ID: 23771556
[TBL] [Abstract][Full Text] [Related]
50. Neoadjuvant chemotherapy with MRI monitoring for breast cancer.
Dave RV; Millican-Slater R; Dodwell D; Horgan K; Sharma N
Br J Surg; 2017 Aug; 104(9):1177-1187. PubMed ID: 28657689
[TBL] [Abstract][Full Text] [Related]
51. Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancer.
Yoshioka T; Hosoda M; Yamamoto M; Taguchi K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
Breast Cancer; 2015 Mar; 22(2):185-91. PubMed ID: 23645542
[TBL] [Abstract][Full Text] [Related]
52. Breast Cancer Subtype Influences the Accuracy of Predicting Pathologic Response by Imaging and Clinical Breast Exam After Neoadjuvant Chemotherapy.
Waldrep AR; Avery EJ; Rose FF; Midathada MV; Tilford JA; Kolberg HC; Hutchins MR
Anticancer Res; 2016 Oct; 36(10):5389-5395. PubMed ID: 27798904
[TBL] [Abstract][Full Text] [Related]
53. Clinicopathological features of tumors as predictors of the efficacy of primary neoadjuvant chemotherapy for operable breast cancer.
Shien T; Akashi-Tanaka S; Miyakawa K; Hojo T; Shimizu C; Seki K; Ando M; Kohno T; Taira N; Doihara H; Katsumata N; Fujiwara Y; Kinoshita T
World J Surg; 2009 Jan; 33(1):44-51. PubMed ID: 18953600
[TBL] [Abstract][Full Text] [Related]
54. Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.
Masuda N; Lee SJ; Ohtani S; Im YH; Lee ES; Yokota I; Kuroi K; Im SA; Park BW; Kim SB; Yanagita Y; Ohno S; Takao S; Aogi K; Iwata H; Jeong J; Kim A; Park KH; Sasano H; Ohashi Y; Toi M
N Engl J Med; 2017 Jun; 376(22):2147-2159. PubMed ID: 28564564
[TBL] [Abstract][Full Text] [Related]
55. Molecular subtypes and tumor response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Kim SI; Sohn J; Koo JS; Park SH; Park HS; Park BW
Oncology; 2010; 79(5-6):324-30. PubMed ID: 21430399
[TBL] [Abstract][Full Text] [Related]
56. [Analysis of associations between molecular subtypes and responses to neoadjuvant chemotherapy in primary breast cancer patients].
Zhou YJ; Ying M; He YJ; Liu YQ; Fan ZQ; Fan T; Li JF; Wang TF; Xie YT; Lu AP; Ouyang T
Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(22):1711-5. PubMed ID: 24124677
[TBL] [Abstract][Full Text] [Related]
57. Changes of expression of estrogen and progestrone receptors, human epithelial growth factor receptor 2 and Ki-67 after neoadjuvant chemotherapy in the treatment of breast cancer.
Li ML; Dong Y; Luan SL; Zhao ZH; Ning FL
J Biol Regul Homeost Agents; 2016; 30(4):1059-1065. PubMed ID: 28078854
[TBL] [Abstract][Full Text] [Related]
58. Structure and Molecular Dynamics Simulations of Protein Tyrosine Phosphatase Non-Receptor 12 Provide Insights into the Catalytic Mechanism of the Enzyme.
Dong H; Zonta F; Wang S; Song K; He X; He M; Nie Y; Li S
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29278368
[TBL] [Abstract][Full Text] [Related]
59. GABA
Wei B; Zhu Y; Yang P; Han Y; Wang S; Wang X; Xia S; Song X; Zhang Z; Wang S; Rondard P; Pin JP; Jiang X; Liu J
iScience; 2021 Nov; 24(11):103311. PubMed ID: 34778730
[TBL] [Abstract][Full Text] [Related]
60. Erratum: Analysis of Tau Protein Expression in Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Different Molecular Subtypes of Breast Cancer.
Lei C; Yang C; Xia B; Ji F; Zhang Y; Gao H; Xiong Q; Lin Y; Zhuang X; Zhang L; Zhu T; Cheng M; Yang M; Wang K
J Breast Cancer; 2020 Apr; 23(2):230-231. PubMed ID: 32395382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
